MRP1 but not MDR1 is associated with response to neoadjuvant chemotherapy in breast cancer patients

Mohsen Taheri1, Frouzandeh Mahjoubi

  • 1Division of Medical Biotechnology, National Institute of Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran.

Disease Markers
|March 14, 2013
PubMed

Insights

Multidrug resistance 1 (MDR1) and multidrug resistance associated protein 1 (MRP1) are elevated in breast tumors. Only MRP1 expression correlated with chemotherapy response, suggesting its clinical significance in breast cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Chemotherapeutic resistance is a major challenge in breast cancer treatment.
  • The roles of multidrug resistance 1 (MDR1) and multidrug resistance associated protein 1 (MRP1) in drug resistance are established in many cancers, but their clinical significance in breast cancer is debated.
  • Understanding MDR1 and MRP1 expression is crucial for predicting treatment outcomes.

Purpose of the Study:

  • To investigate the expression levels of MDR1 and MRP1 in breast cancer tissues compared to normal tissues.
  • To determine the correlation between MDR1 and MRP1 expression and clinical response to neoadjuvant chemotherapy in breast cancer patients.
  • To assess the relationship between MDR1/MRP1 expression and clinicopathological features.

Main Methods:

  • Gene expression analysis using real-time reverse transcription polymerase chain reaction (RT-PCR).
  • Study included 54 breast cancer tumors and adjacent normal tissues.
  • Expression levels were analyzed before neoadjuvant chemotherapy.

Main Results:

  • Both MDR1 and MRP1 expression levels were significantly higher in breast tumors than in adjacent normal tissues.
  • A significant correlation was observed between MRP1 expression and response to chemotherapy.
  • No significant association was found between MDR1 expression and response to treatment.
  • MDR1 and MRP1 expression were independent of tumor size, histological grade, and hormone receptor status.

Conclusions:

  • MRP1, but not MDR1, expression is associated with chemotherapy response in breast cancer patients.
  • Elevated MDR1 and MRP1 expression in tumors suggests their involvement in breast cancer drug resistance.
  • MRP1 may serve as a potential biomarker for predicting treatment efficacy in breast cancer.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...